Search Results

Clinical Impact of Repositionable EVAR Delivery

PANEL Barry T. Katzen, MD, is Medical Director, Baptist Cardiac & Vascular Institute, in Miami, Florida. He has disclosed that he is a paid consultant to Gore & Associates, Medtronic, Inc., and Boston Scientific Corporation. Dr. Katzen may be reached at barryk@baptisthealth.net.

VIVA 2011: Long-Term RESILIENT Data for Nitinol Stenting in the SFA

October 18, 2011—Barry Katzen, MD, presented late-breaking long-term clinical trial results from RESILIENT at the VIVA 2011: Vascular Interventional Advances meeting in Las Vegas, Nevada.

Phase-III Trial Begins to Evaluate Angiomax in Patients Undergoing Peripheral Endovascular Procedures

October 9, 2013—The Medicines Company reported enrollment of the first patient in a phase-III clinical trial comparing the anticoagulant Angiomax (bivalirudin) to unfractionated heparin (UFH) in patients undergoing peripheral endovascular intervention (PEI).

Miami Cardiac & Vascular Institute Completes State-of-the-Art Expansion Project

March 2, 2017–Miami Cardiac & Vascular Institute (MCVI) announced the completion of its 3-year, $120 million expansion project on the Baptist Hospital campus.

CDC Recognizes and Codifies CLI and CLTI in ICD-10-CM

October 5, 2020—A coalition organized by the CLI Global Society announced that its proposal to distinctly recognize “critical limb ischemia” (CLI) and “chronic limb-threatening ischemia” (CLTI) in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) was approved by the Centers for Disease Control and Prevention and went into effect October 1.

Philips Collaborates With Leading Institutes to Combine Its Spectral CT Imaging and Image-Guided Therapy Technologies for Interventional Suite

November 24, 2021—Royal Philips announced it is collaborating with leading clinical institutes such as Mayo Clinic in Rochester, Minnesota and Baptist Health’s Miami Cardiac & Vascular Institute in Miami, Florida, to bring its spectral CT imaging technology into a hybrid angio CT suite.

In Memoriam: Interventional Radiology Pioneer Mark H. Wholey, MD

Mark H. Wholey, MD, FSIR, a founding member of the Society of Interventional Radiology (SIR) and the society’s president from 1982 to 1983, died on February 25 at the age of 97. He is survived by his wife, Roseanne, and five children. A Mass of Christian Burial was celebrated on March 4 at St. Paul Cathedral in Pittsburgh, Pennsylvania.

EkoSonic System Gains FDA Clearance for Pulmonary Embolism Treatment

May 23, 2014—Ekos Corporation, a BTG International group company, has announced the US Food and Drug Administration clearance of its EkoSonic Endovascular System for the ultrasound-facilitated, controlled, and selective infusion of physician-specified fluids (including thrombolytics) into the vasculature for treating pulmonary embolism (PE).

First Procedure in United Kingdom Performed With Hansen Medical's Magellan Robotic System for PAE

September 29, 2015—Hansen Medical, Inc. announced the completion of the first robot-assisted prostatic artery embolization (PAE) procedure in the United Kingdom with the company’s Magellan robotic system.

Philips Launches Next-Generation Azurion Image-Guided Therapy Platform

February 22, 2017—Royal Philips announced the global launch of Azurion, the company's next-generation image-guided therapy platform for interventional labs.